issued shares in Indo Rama Synthetics (India) Limited (“IRSL”), equaling to approximately 31.79% of IRSL’s enlarged share capital (the “Share Purchase”) at the price of INR 36 per share. The Company would

by its indirect subsidiary Indorama Netherlands B.V. (“INBV”) of 83,000,000 newly issued shares in Indo Rama Synthetics (India) Limited (“IRSL”), equaling to approximately 31.79% of IRSL’s enlarged

or 22.90% over the same period of last year of which hospital revenues totally raised by 10.16% along with the enlarged customer base of Subsidiary (AMARC) showing 15.67% of revenues’ growth. In

year, the Company has not yet earned income from Excellence Center (New Building) planned to official grand opening in the following year of February 2018) along with the enlarged customer base of the

committees and/or delegated person to disposition of the common shares held in Prinda Public Company Limited (“PRINDA”), which is manufacturing, trading and transporting of brick, stone and sand for

slowdown in the country. Transport operators in the country to be competitive and stop transporting cement powder because management determined that it was not worth the money to get the job done. The

the country. Transport operators in the country to be competitive and stop transporting cement powder because management determined that it was not worth the money to get the job done. The company

country slowdown. The transport operators in the country to be competitive and stop transporting cement powder because management determined that it was not worth for the money to get the job done. The

70.82%, 77.04% and 75.18% for 2021, 2022 and 2023, respectively. The reason is that in 2023, the company has increase in product exports, resulting in costs and expenses for transporting goods to increase

shareholders, and subscribe Phoenix’s newly issued shares of 180.00 million shares, totaling 314.60 million shares or 55 percent of total enlarged shares of Phoenix. List of shareholders before and after